NEVVI Medicare utilization intelligence
or browse by specialty
Medicare · fee-for-service Part B

Hematology/Oncology — Medicare Part B billing by state

$1.56B
Medicare payments
189
Physician groups
108,607,079
Services

189 physician groups whose primary specialty is Hematology/Oncology billed $1.56B to Medicare fee-for-service in 2024.

Calendar year 2024 · Medicare fee-for-service Part B

Physician groups whose primary specialty is Hematology/Oncology, by billing state · CY2024
State Groups Services Beneficiary-episodes Medicare payments Standardized payments ↓ Payments / group Services / group
Florida 21 32,488,484 1,767,402 $403,365,749 $402,715,110 $19,207,893 1,547,071
California 35 10,820,268 413,910 $166,600,340 $159,402,983 $4,760,010 309,151
Arkansas 3 5,091,621 301,388 $80,108,309 $81,824,000 $26,702,770 1,697,207
Maryland 7 5,540,097 203,467 $79,614,065 $78,210,850 $11,373,438 791,442
New Jersey 12 5,540,503 229,942 $77,463,209 $74,108,143 $6,455,267 461,709
Kansas 1 4,325,855 91,508 $68,291,533 $68,501,955 $68,291,533 4,325,855
Virginia 11 3,252,476 182,628 $66,689,991 $66,396,412 $6,062,726 295,680
Pennsylvania 15 4,056,590 148,967 $66,534,068 $65,967,290 $4,435,605 270,439
Tennessee 6 3,877,956 280,078 $64,115,264 $65,832,574 $10,685,877 646,326
Illinois 17 5,125,226 198,645 $64,044,177 $64,051,361 $3,767,305 301,484
Arizona 5 3,566,990 107,991 $47,201,370 $47,664,802 $9,440,274 713,398
Texas 17 3,270,132 117,943 $45,507,591 $45,939,287 $2,676,917 192,361
South Carolina 5 2,972,280 115,696 $42,722,980 $42,926,751 $8,544,596 594,456
Mississippi 4 1,786,466 68,427 $34,586,305 $35,641,210 $8,646,576 446,616
Georgia 10 2,307,653 119,090 $32,257,124 $32,613,182 $3,225,712 230,765
North Carolina 8 2,012,378 95,829 $28,809,193 $29,034,540 $3,601,149 251,547
Ohio 11 2,051,033 69,948 $22,435,791 $22,621,185 $2,039,617 186,458
Indiana 4 1,453,376 67,981 $21,034,474 $21,338,210 $5,258,619 363,344
Nevada 5 995,087 47,801 $19,612,209 $19,745,637 $3,922,442 199,017
Delaware 1 587,683 17,155 $16,489,324 $16,382,302 $16,489,324 587,683
Maine 1 955,804 33,087 $13,536,376 $13,498,181 $13,536,376 955,804
Louisiana 6 487,989 33,725 $10,580,999 $11,087,413 $1,763,500 81,332
Michigan 8 678,980 53,317 $10,756,632 $10,882,310 $1,344,579 84,872
Washington 3 959,370 42,530 $10,600,867 $10,587,646 $3,533,622 319,790
Missouri 10 357,470 41,087 $9,614,054 $9,778,809 $961,405 35,747
New Mexico 3 467,806 43,191 $7,285,575 $7,339,030 $2,428,525 155,935
Nebraska 1 432,345 6,663 $5,854,846 $5,850,661 $5,854,846 432,345
Alaska 2 256,421 11,088 $5,281,957 $5,029,880 $2,640,978 128,210
New York 10 499,654 32,735 $5,420,544 $4,937,457 $542,054 49,965
Alabama 2 129,564 2,928 $4,188,215 $4,294,102 $2,094,107 64,782
Minnesota 1 299,158 5,862 $4,292,395 $4,291,708 $4,292,395 299,158
Connecticut 4 545,120 13,490 $4,372,598 $4,177,408 $1,093,149 136,280
Vermont 2 243,959 7,497 $4,098,402 $4,055,101 $2,049,201 121,980
Massachusetts 5 286,012 11,511 $3,664,602 $3,586,923 $732,920 57,202
Iowa 2 195,089 6,035 $3,087,795 $3,133,590 $1,543,898 97,544
Oregon 3 231,295 4,557 $2,747,305 $2,696,020 $915,768 77,098
South Dakota 1 83,299 1,592 $1,576,414 $1,573,690 $1,576,414 83,299
PR 8 65,623 5,234 $1,438,252 $1,466,168 $179,782 8,203
XX 1 68,827 3,535 $1,401,626 $1,408,369 $1,401,626 68,827
Kentucky 2 55,648 1,915 $763,065 $783,987 $381,533 27,824
New Hampshire 1 163,511 1,965 $801,370 $764,974 $801,370 163,511
Oklahoma 3 9,820 5,877 $533,973 $568,011 $177,991 3,273
Wisconsin 3 7,920 3,038 $354,382 $374,799 $118,127 2,640
District of Columbia 2 1,528 611 $110,302 $101,420 $55,151 764
VI 1 1,450 559 $98,858 $99,550 $98,858 1,450
Utah 1 1,017 342 $35,367 $35,776 $35,367 1,017
Colorado 2 187 143 $13,964 $14,522 $6,982 94
Rhode Island 1 59 47 $4,774 $4,241 $4,774 59
Ranked by standardized payments — the cross-state basis (regional price differences removed). The Medicare payments column shows what Medicare actually paid. Each state opens the ranked Hematology/Oncology market for that state's biggest code.

Need this specialty's market in one document?

Notify me at launch

Each group carries one specialty label — the specialty most common among its clinicians in CMS's Doctors and Clinicians register — so every figure on this page counts groups, not individual clinicians. An organization's entire Medicare billing is credited to that one label, so a specialty's totals reflect how organizations are labeled, not the specialty of each service; large multi-specialty organizations — where no single specialty is a majority of the clinicians — account for much of the volume shown under many specialties. Totals include only volume that can be credited to a single group; clinicians registered with more than one group are left out of group totals and shown as “—” elsewhere on Nevvi. Clinicians not registered with any group, and groups without a specialty label, are also not included. A group is counted in every state its clinicians bill Medicare from, so state figures overlap and never sum to the national figure.

All figures are Medicare fee-for-service Part B only; Medicare Advantage claims are not included. Cross-state comparisons use standardized payments, which remove regional differences in what Medicare pays; services without a standardized amount — mainly Part B drugs — are not in that column, and the Medicare payments column shows what Medicare actually paid. Beneficiary counts are beneficiary-episodes: one person treated in more than one setting or state is counted in each.

Top codes by Medicare payments CY2024

Code Services Medicare payments ↓ Largest state markets
J9271 · Injection, pembrolizumab, 1 mg 9,526,504 $422,139,574 FLCAARMDNJ
J0897 · Injection, denosumab, 1 mg 6,237,333 $127,209,663 FLCAARMDNJ
J9144 · Injection, daratumumab, 10 mg and hyaluronidase-fihj 2,926,740 $114,158,670 FLCAARMDNJ
99214 · Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more 1,010,968 $93,292,134 FLCAARMDNJ
J9299 · Injection, nivolumab, 1 mg 3,024,549 $74,081,289 FLCAARMDNJ
96413 · Administration of chemotherapy into vein, 1 hour or less 371,238 $36,735,135 FLCAARMDNJ
99215 · Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more 264,178 $34,826,519 FLCAARMDNJ
78815 · Nuclear medicine study from skull base to mid-thigh with ct scan 27,195 $32,856,563 FLCAARMDNJ
J1569 · Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg 911,263 $32,406,652 FLCAARMDNJ
J1437 · Injection, ferric derisomaltose, 10 mg 2,012,512 $31,709,410 FLCAARMDNJ
J0881 · Injection, darbepoetin alfa, 1 microgram (non-esrd use) top by services 8,356,846 $19,301,481 FLCAARMDNJ
J1439 · Injection, ferric carboxymaltose, 1 mg top by services 13,849,137 $12,014,941 FLCAARMDNJ
J0185 · Injection, aprepitant, 1 mg top by services 3,681,492 $4,909,278 FLCAARMDNJ
Q0138 · Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) top by services 10,486,001 $2,876,723 FLCAARMDNJ
Q5110 · Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram top by services 3,319,322 $716,469 FLCAARMDNJ
Q9967 · Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml top by services 2,938,937 $297,538 FLCAARMDNJ
Top codes by Medicare payments and by services (both rankings, duplicates merged; capped, never the full code list). “top by services” marks codes here on service volume rather than payments. Each code is searchable free at full depth; state links open that code's ranked market page.

Every code above is searchable free at full depth. Ranking organizations across several codes at once — one combined market view — is part of a Nevvi subscription.

Notify me at launch